Early Detection of COPD Exacerbations Using Home Monitoring Device
Starting soon
Conditions studied: COPD Exacerbation
In brief
The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.
Key facts
- Study ID
- NCT07554352
- Run by
- RespirAI US Inc
- People needed
- 30
- Starts
- 2026-05-01
- Expected to finish
- 2027-05-01
- Last updated by the study team
- 2026-04-28
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >21 years.
- Physician-diagnosed COPD at least 6 months prior to screening visit.
- Two or more moderate COPD exacerbations in the past 6 months or 1 severe exacerbation during the past 6 months.
- Free of exacerbation for 1 month before enrollment.
You may not qualify if…
- Unable or willing to sign an informed consent.
- Unable to complete the 6-minute walk test due to physical or mental health conditions.
- Patients with cardiac pacemaker, defibrillators, or other implanted electronic devices.
- Pregnancy
- Study clinician determines that the patient is unable or unwilling to comply with all study procedures.
Where it is running
- Methodist Physicians Clinic — Omaha, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.